Quality of life after transanal total mesorectal excision – our experience
Authors:
M. Svoboda; V. Procházka
; T. Grolich; Z. Kala
Authors place of work:
Chirurgická klinika Fakultní nemocnice Brno a Lékařské fakulty Masarykovy univerzity v Brně
Published in the journal:
Rozhl. Chir., 2021, roč. 100, č. 11, s. 534-542.
Category:
Original articles
doi:
https://doi.org/10.33699/PIS.2021.100.11.534–542
Summary
Introduction: Functional outcomes and quality of life (QoL) after transanal total mesorectal excision (TaTME) are very important factors in the evaluation of TaTME in comparison with other approaches to TME. The most common functional problems after resection of the rectum include bowel, urologic and sexual dysfunctions. In this study, we present our experience with QoL after TaTME; the results are compared with worldwide literature in the discussion.
Methods: QoL was assessed by a questionnaire. The total of 54 patients were analysed. A general questionnaire for oncological diseases was used – European Organisation for Research and Treatment of Cancer (EORTC)-QLQ-C30, together with EORTC-QLQ-CR29 – a specific questionnaire for colorectal cancer. The Low Anterior Resection Syndrome (LARS) score was also obtained in all patients. Mean follow-up was 42.65 months (range 9–91 months).
Results: The mean LARS score in patients undergoing TaTME was 30.7 while a major LARS was observed in 64.2% of those with LARS. Of all of the symptoms in the EORTC-QLQ-C30 survey, the most serious problems which affected patients undergoing TaTME were diarrhoea (30.25), fatigue (23.87) and insomnia (20.37). In the QLQ-CR29 survey the problems included flatulence (50.94), faecal incontinence (45.06) and stool frequency (35.19). The results of EORTC-QLQ-C30 and QLQ-CR29 are quite heterogeneous.
Conclusion: In this study the QoL of patients with advanced rectal tumours (of whom 81.5% received neoadjuvant therapy) undergoing TaTME is comparable to results in the current literature. The most severe symptoms affecting QoL after TaTME are flatulence, faecal incontinence, and stool frequency. Other serious symptoms include fatigue and insomnia. LARS was recorded in 73.6% of patients undergoing TaTME, mostly a major LARS.
Keywords:
transanal total mesorectal excision − quality of life − functional outcomes − low anterior resection syndrome − EORTC
Zdroje
1. Adamina M, Buchs NC, Penna M, et al. St. Gallen consensus on safe implementation of transanal total mesorectal excision. Surg Endosc. 2018;32(3):1091−1103. doi:10.1007/s00464-017-5990-2.
2. Perdawood SK, Thinggaard BS, Bjoern MX. Effect of transanal total mesorectal excision for rectal cancer: comparison of short-term outcomes with laparoscopic and open surgeries. Surg Endosc. 2018;32(5):2312−2321. doi:10.1007/ s00464-017-5926-x.
3. Procházka V, Grolich T, Farkašová M, et al. Our experience with transanal total mesorectal excision (TaTME) procedures in middle and distal rectal tumors. Rozhl Chir. 2020;99(3):124−130. doi:10.33699/ PIS.2020.99.3.124-130.
4. Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology. JNCI J Natl Cancer Inst. 1993;85(5):365−376. doi:10.1093/ jnci/85.5.365.
5. Fayers P, Aaronson NK, Bjordal K, et al. EORTC QLQ-C30 scoring manual. 3rd ed. European Organisation for Research and Treatment of Cancer 2001.
6. Rahbari NN, Waltz J, Hohenberger W, et al. Definition and grading of anastomotic leakage following anterior resection of the rectum: a proposal by the International Study Group of Rectal Cancer. Surgery 2010;147(3):339−351. doi:10.1016/j. surg.2009.10.012.
7. Kang S-B, Cho JR, Jeong S-Y, et al. Quality of life after sphincter preservation surgery or abdominoperineal resection for low rectal cancer (ASPIRE): A longterm prospective, multicentre, cohort study. Lancet Reg Health - West Pac. 2021;6:100087. doi:10.1016/j.lanwpc. 2020.100087.
8. Chapman SJ, Bolton WS, Corrigan N, et al. Cross-sectional review of reporting variation in postoperative bowel dysfunction after rectal cancer surgery: Dis Colon Rectum. 2017;60(2):240−247. doi:10.1097/ DCR.0000000000000649.
9. Allahdadi K, Tostes R, Webb R. Female sexual dysfunction: Therapeutic options and experimental challenges. Cardiovasc Hematol Agents Med Chem. 2009;7(4):260−269. doi:10.2174/187152509789541882.
10. Rosen RC, Cappelleri JC, Smith MD, et al. Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res. 1999;11(6):319−326. doi:10.1038/sj.ijir.3900472.
11. Bregendahl S, Emmertsen KJ, Lous J, et al. Bowel dysfunction after low anterior resection with and without neoadjuvant therapy for rectal cancer: a population- based cross-sectional study. Colorectal Dis. Published online April 2013:n/a-n/a. doi:10.1111/codi.12244.
12. Pollack J, Holm T, Cedermark B, et al. Late adverse effects of short-course preoperative radiotherapy in rectal cancer. Br J Surg. 2006;93(12):1519−1525. doi:10.1002/bjs.5525.
13. Pietrzak L, Bujko K, Nowacki MP, et al. Quality of life, anorectal and sexual functions after preoperative radiotherapy for rectal cancer: Report of a randomised trial. Radiother Oncol. 2007;84(3):217−225. doi:10.1016/j.radonc. 2007.07.007.
14. Appelt AL, Pløen J, Harling H, et al. Highdose chemoradiotherapy and watchful waiting for distal rectal cancer: a prospective observational study. Lancet Oncol. 2015;16(8):919−927. doi:10.1016/ S1470-2045(15)00120-5.
15. Hupkens BJP, Martens MH, Stoot JH, et al. Quality of life in rectal cancer patients after chemoradiation: Watch-andwait policy versus standard resection – A matched-controlled study. Dis Colon Rectum. 2017;60(10):1032−1040. doi:10.1097/DCR.0000000000000862.
16. Detering R, Roodbeen SX, van Oostendorp SE, et al. Three-year nationwide experience with transanal total mesorectal excision for rectal cancer in the Netherlands: A propensity score-matched comparison with conventional laparoscopic total mesorectal excision. J Am Coll Surg. 2019;228(3):235−244.e1. doi:10.1016/j. jamcollsurg.2018.12.016.
17. Mosquera C, Licardie E, Bravo D, et al. Fecal incontinence after surgical treatment of middle–low rectal cancer. Laparoscopic low anterior resection versus tatme. Surg Endosc. 2019;33(Suppl 1):S281.
18. Veltcamp Helbach M, Koedam TWA, Knol JJ, et al. Residual mesorectum on postoperative magnetic resonance imaging following transanal total mesorectal excision (TaTME) and laparoscopic total mesorectal excision (LapTME) in rectal cancer. Surg Endosc. 2019;33(1):94−102. doi:10.1007/s00464-018-6279-9.
19. D’Ambrosio G, Picchetto A, Campo S, et al. Quality of life in patients with loco-regional rectal cancer after ELRR by TEM versus VLS TME after nChRT: long-term results. Surg Endosc. 2019;33(3):941−948. doi:10.1007/s00464-018-6583-4.
20. Filips A, Haltmeier T, Kohler A, et al. LARS is associated with lower anastomoses, but not with the transanal approach in patients undergoing rectal cancer resection. World J Surg. 2021;45(3):873−879. doi:10.1007/s00268-020-05876-6.
21. Bjoern MX, Nielsen S, Perdawood SK. Quality of life after surgery for rectal cancer: a comparison of functional outcomes after transanal and laparoscopic approaches. J Gastrointest Surg Off J Soc Surg Aliment Tract. 2019;23(8):1623−1630. doi:10.1007/ s11605-018-4057-6.
22. Choy KT, Yang TWW, Prabhakaran S, et al. Comparing functional outcomes between transanal total mesorectal excision (TaTME) and laparoscopic total mesorectal excision (LaTME) for rectal cancer: a systematic review and meta-analysis. Int J Colorectal Dis. 2021;36(6):1163−1174. doi:10.1007/s00384-021-03849-2.
23. van der Heijden JAG, Qaderi SM, Verhoeven R, et al. Transanal total mesorectal excision and low anterior resection syndrome. Br J Surg. Published online April 9, 2021:znab056. doi:10.1093/bjs/znab056.
24. Ziv Y, Zbar A, Bar-Shavit Y, et al. Low anterior resection syndrome (LARS): cause and effect and reconstructive considerations. Tech Coloproctology. 2013;17(2):151−162. doi:10.1007/ s10151-012-0909-3.
25. Andersson J, Abis G, Gellerstedt M, et al. Patient-reported genitourinary dysfunction after laparoscopic and open rectal cancer surgery in a randomized trial (COLOR II). Br J Surg. 2014;101(10):1272−1279. doi:10.1002/bjs.9550.
26. van der Heijden JAG, Koëter T, Smits LJH, et al. Functional complaints and quality of life after transanal total mesorectal excision: a meta‐analysis. Br J Surg. 2020;107(5):489−498. doi:10.1002/ bjs.11566.
27. Celentano V, Cohen R, Warusavitarne J, et al. Sexual dysfunction following rectal cancer surgery. Int J Colorectal Dis. 2017;32(11):1523−1530. doi:10.1007/ s00384-017-2826-4.
28. Li Y, Bai X, Niu B, et al. A prospective study of health related quality of life, bowel and sexual function after TaTME and conventional laparoscopic TME for mid and low rectal cancer. Tech Coloproctology. 2021;25(4):449-459. doi:10.1007/s10151- 020-02397-1.
29. WHOQOL: Measuring quality of life. World Health Organization (WHO). Accessed June 1, 2021. https://www.who. int/tools/whoqol.
30. Hnilicová H, Bencko V. Kvalita života – vymezení pojmu a jeho význam pro medicínu a zdravotnictví. Prakt Lék. 2005;85(11):656−660.
31. Emmertsen KJ, Laurberg S, Jess P, et al. Impact of bowel dysfunction on quality of life after sphincter-preserving resection for rectal cancer. Br J Surg. 2013;100(10):1377−1387. doi:10.1002/ bjs.9223.
32. Mora L, Zarate A, Serra-Aracil X, et al. Functional impairment and quality of life after rectal cancer surgery. Cir Cir. 2018;86(2):140−147. doi:10.24875/CIRU. M18000022.
33. Veltcamp Helbach M, Koedam TWA, Knol JJ, et al. Quality of life after rectal cancer surgery: differences between laparoscopic and transanal total mesorectal excision. Surg Endosc. 2019;33(1):79−87. doi:10.1007/s00464-018-6276-z.
34. Kauff DW, Roth YDS, Bettzieche RS, et al. Fecal incontinence after total mesorectal excision for rectal cancer—impact of potential risk factors and pelvic intraoperative neuromonitoring. World J Surg Oncol. 2020;18(1):12. doi:10.1186/ s12957-020-1782-6.
35. Kauff D, Koch K, Kempski O, et al. Impact of selective surgical pelvic autonomic nerve damage on the evoked neuromonitoring signal of the internal anal sphincter. Biomed Eng Biomed Tech. 2012;57(SI-1 Track-H). doi:10.1515/bmt-2012-4209.
Štítky
Surgery Orthopaedics Trauma surgeryČlánok vyšiel v časopise
Perspectives in Surgery
2021 Číslo 11
- Spasmolytic Effect of Metamizole
- Metamizole at a Glance and in Practice – Effective Non-Opioid Analgesic for All Ages
- Metamizole in perioperative treatment in children under 14 years – results of a questionnaire survey from practice
Najčítanejšie v tomto čísle
- Total mesorectal excision for rectal cancer – laparoscopic versus robotic approach
- Quality of life after transanal total mesorectal excision – our experience
- Midgut volvulus in adult age associated with congenital malrotation – case report
- TaTME (transanal total mesorectal excision) – state of the art